88 related articles for article (PubMed ID: 15183907)
1. Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V.
Biagi G; Giorgi I; Livi O; Nardi A; Calderone V; Martelli A; Martinotti E; LeRoy Salerni O
Eur J Med Chem; 2004 Jun; 39(6):491-8. PubMed ID: 15183907
[TBL] [Abstract][Full Text] [Related]
2. 1,5-Diarylsubstituted 1,2,3-triazoles as potassium channel activators. VI.
Biagi G; Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2004 May; 59(5):397-404. PubMed ID: 15120319
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications of benzanilide derivatives, effective potassium channel openers. X.
Calderone V; Coi A; Fiamingo FL; Giorgi I; Leonardi M; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2006 Dec; 41(12):1421-9. PubMed ID: 17030483
[TBL] [Abstract][Full Text] [Related]
4. Different potassium channels are involved in relaxation of rat renal artery induced by P1075.
Novakovic A; Pavlovic M; Milojevic P; Stojanovic I; Nenezic D; Jovic M; Ugresic N; Kanjuh V; Yang Q; He GW
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):24-30. PubMed ID: 22225832
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
[TBL] [Abstract][Full Text] [Related]
6. Blocking the L-type Ca2+ channel (Cav 1.2) is the key mechanism for the vascular relaxing effect of Pterodon spp. and its isolated diterpene methyl-6α-acetoxy-7β-hydroxyvouacapan-17β-oate.
de Fátima Reis C; de Andrade DM; Junior Neves B; de Almeida Ribeiro Oliveira L; Pinho JF; da Silva LP; Dos Santos Cruz J; Bara MT; Andrade CH; Rocha ML
Pharmacol Res; 2015 Oct; 100():242-9. PubMed ID: 26296533
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries.
Niu LG; Zhang MS; Liu Y; Xue WX; Liu DB; Zhang J; Liang YQ
Eur J Pharmacol; 2008 Feb; 580(1-2):169-74. PubMed ID: 17997400
[TBL] [Abstract][Full Text] [Related]
8. Vasorelaxant effects of Brillantaisia nitens Lindau (Acanthaceae) extracts on isolated rat vascular smooth muscle.
Dimo T; Mtopi OS; Nguelefack TB; Kamtchouing P; Zapfack L; Asongalem EA; Dongo E
J Ethnopharmacol; 2007 Apr; 111(1):104-9. PubMed ID: 17250985
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of novel 2-(alpha-alkoxyimino)benzylpyridine derivatives as K+ channel openers.
Maekawa T; Yamamoto S; Igata Y; Ikeda S; Watanabe T; Shiraishi M
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1994-2004. PubMed ID: 9433769
[TBL] [Abstract][Full Text] [Related]
10. The vasodilator mechanism of sulfur dioxide on isolated aortic rings of rats: Involvement of the K+ and Ca2+ channels.
Zhang Q; Meng Z
Eur J Pharmacol; 2009 Jan; 602(1):117-23. PubMed ID: 19049805
[TBL] [Abstract][Full Text] [Related]
11. 5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. I.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Eur J Med Chem; 2000; 35(7-8):715-20. PubMed ID: 10960187
[TBL] [Abstract][Full Text] [Related]
12. Novel 1,4-benzothiazine derivatives as large conductance Ca2+-activated potassium channel openers.
Calderone V; Spogli R; Martelli A; Manfroni G; Testai L; Sabatini S; Tabarrini O; Cecchetti V
J Med Chem; 2008 Aug; 51(16):5085-92. PubMed ID: 18680269
[TBL] [Abstract][Full Text] [Related]
13. New 5-substituted-1-(2-hydroxybenzoyl)-benzotriazoles, potassium channel activators. IV.
Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL; Calderone V; Martinotti E
Farmaco; 2001 Nov; 56(11):827-34. PubMed ID: 11765034
[TBL] [Abstract][Full Text] [Related]
14. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
Zhao SY; Huang WL; Zhang HB
Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the vasorelaxant effect of 1, 5-dihydroxy-2, 3-dimethoxy-xanthone, an active metabolite of 1-hydroxy-2, 3, 5-trimethoxy-xanthone isolated from a Tibetan herb, Halenia elliptica, on rat coronary artery.
Wang Y; Shi JG; Wang MZ; Che CT; Yeung JH
Life Sci; 2008 Jan; 82(1-2):91-8. PubMed ID: 18045622
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation.
Raffetto JD; Ross RL; Khalil RA
J Vasc Surg; 2007 Feb; 45(2):373-80. PubMed ID: 17264019
[TBL] [Abstract][Full Text] [Related]
18. Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Farmaco; 2001 Nov; 56(11):841-9. PubMed ID: 11765036
[TBL] [Abstract][Full Text] [Related]
19. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
[TBL] [Abstract][Full Text] [Related]
20. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
